Paul Saladino· MD
so is something Shady afoot here I think we must be wary of that possibility in fact I think there's a lot to make us quite suspicious of that at this point
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
so is something Shady afoot here I think we must be wary of that possibility in fact I think there's a lot to make us quite suspicious of that at this point
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
in the case of statins the vast majority of Trials are sponsored by the industry as I mentioned Ronald Reagan 1980 Etc only one major non-industry-funded study on statins has been done it is the all-hat trial the antihypertensive and lipid lowering treatment to prevent heart attack trial acronym all hat which showed pravastatin had no significant benefit in reducing either all cause mortality or coronary heart disease in primary prevention